🔎 Trials Near Me

Hjem › Småcellet lungekræft › Nebraska

Småcellet lungekræft kliniske forsøg i Nebraska

10 studier for Småcellet lungekræft søger deltagere på steder i Nebraska.

Byer i Nebraska

Officiel studietekst (engelsk)

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

  • Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT03460977

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

  • Nebraska Cancer Specialists, Omaha
  • XCancer, Omaha
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07189871

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  • University of Nebraska Medical Center, Omaha
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07472517

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

  • Nebraska Cancer Specialists, Omaha
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07278479

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

  • Oncology Hematology West PC, Omaha
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 17. sep. 2026 · NCT07778316

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • Nebraska Hematology-Oncology (NHO), Lincoln
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT06712355

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

  • Nebraska Cancer Specialists, Grand Island
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT06095505

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

  • University of Nebraska Medical Center, Omaha
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT06203210

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. mar. 2026 · NCT06681220

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  • Nebraska Cancer Specialists, Omaha
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 18. feb. 2026 · NCT07030257

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.